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Abstract
Cyclic thrombocytopenia (CTP) is a rare disorder characterized by periodic decreases and increases in plate-
let levels. Each cycle usually spans a period of 3-5 weeks. Clinical features are similar to those of idiopathic 
thrombocytopenic purpura (ITP), so patients are frequently misdiagnosed as having ITP . However, CTP 
usually does not respond to most treatments used in ITP such as corticosteroids, splenectomy and intrave-
nous immunoglobulin. In this case report, we present a 33-year-old woman with CTP misdiagnosed as ITP . 
(Turk J Hematol 2010; 27: 196-9)
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Özet
Siklik trombositopeni (ST) trombosit seviyelerinde periyodik düşüş ve yükselmeler ile karakterize olan 
nadir görülen bir hastalıktır. Bir siklusun uzunluğu genellikle 3-5 hafta arasındadır. Hastalığın klinik özel-
likleri idiyopatik trombositopenik purpura (İTP) ile benzerlik gösterdiğinden hastalara sık olarak 
yanlışlıkla İTP tanısı koyulmaktadır. Ancak ST genellikle kortikosteroidler, splenektomi ve intravenöz 
immünoglobulin gibi İTP tedavilerine yanıt vermez. Bu olgu sunusunda öncesinde İTP tanısı ile takip 
edilmiş 33 yaşında bir kadın hasta sunuyoruz. 
(Turk J Hematol 2010; 27: 196-9)
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Cyclic thrombocytopenia (CTP) is a rare disorder 
characterized by periodic decreases and increases 
in platelet levels [1]. Each cycle usually spans a 
period of 3-5 weeks. The platelet counts fluctuate by 
a large scale on a periodic basis. In the reported 
cases, the median nadir and peak platelet counts 
are 10x109/L (range 1-90 x109/L) and 330x109/L 
(range 72-2300 x109/L) [2]. Rebound thrombocyto-
sis (> 500x109/L) without therapy is an important 
and distinctive feature for CTP . Women are affected 
more than men. Although some cases have been 
reported in myeloproliferative diseases, most cases 
are idiopathic [3,4]. The pathophysiology is unclear. 
Some potential mechanisms are autoimmune plate-
let destruction, megakaryocytic hypoplasia/aplasia, 
and infectious and hormonal etiology. Clinical pre-
sentation is not different from that of idiopathic 
thrombocytopenic purpura (ITP). Some patients are 
asymptomatic. Patients may experience easy bruis-
ing, gingival bleeding, recurrent epistaxis, menor-
rhagia, and hematuria. They may present with more 
serious bleeding like gastrointestinal or central ner-
vous system hemorrhages. In most cases, CTP is 
not considered as a differential diagnosis so patients 
are diagnosed and treated as having ITP . CTP usu-
ally does not respond to most treatments used in 
ITP such as corticosteroids, splenectomy and intra-
venous immunoglobulin (IVIG). In this condition, a 
diagnosis of CTP should be considered. Close 
observation without treatment seem to be the best 
management if clinically permissible. There are 
some case reports with complete remission after 
hormonotherapy (danazol and sex hormones) [5-8]. 
Case Report
A 33-year-old woman was admitted to the hospi-
tal in April 2006 with purpura. Initial complete blood 
cell count showed thrombocytopenia (platelet 
count: 6x109/L), a mild iron deficiency anemia and 
normal white blood cell count. After making an ini-
tial diagnosis of ITP , the patient received 1 mg/kg/
day methylprednisolone for 1 week, 1 g/day methyl-
prednisolone for 3 days and finally 1 g/kg IVIG ther-
apy. There was no response. Then, the platelet 
count began to increase spontaneously and reached 
750x109/L in the third week. After 45 days, when she 
was admitted to the hospital for the second time 
with purpura, she was administered 2 mg/kg/day 
methylprednisolone. No response was achieved. 
The platelet count reached 800x109/L again without 
therapy. Three months later, when the third purpu-
ric attack occurred, splenectomy was suggested, 
and the patient was admitted to our Hematology 
Department. Oral informed consent was obtained 
from the patient.
She was married, with no children, and was 
working in a hair salon. Her hepatitis B surface anti-
gen was positive. Her physical examination revealed 
petechiae and ecchymoses on her body and 
hemorrhagic bullae in the oral mucosa. There was 
no hepatomegaly, splenomegaly or lymphadeno-
megaly. Signs of Cushing syndrome were seen and 
she was still taking 48 mg methylprednisolone per 
day orally. 
Laboratory investigations revealed: platelet: 
180x109/L, hemoglobin: 10.7 g/dl, hematocrit: 32%, 
MCV: 74 fl, ferritin: 3 ng/ml, SGOT: 240 IU/ml, SGPT: 
280 IU/ml, hepatitis B surface antigen (HBsAg): +, 
and HBV-DNA: +. Peripheral blood smear showed 
hypochromia, microcytosis, and normal leukocyte 
differentiation with no abnormal cells, and the 
platelets had normal morphology. We tapered and 
then stopped the corticosteroid dose, administered 
lamivudine for hepatitis B, and added oral iron 
therapy for iron deficiency anemia. We followed the 
patient every week with complete blood count. The 
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Figure 1. Platelet counts of the patient showed a cyclic pattern. In-
terestingly, lymphocyte and neutrophil counts also showed a cyclic 
pattern without neutropenia. Platelet cycles occurred in synchrony 
with menstruation. It has been thought that the decrease in hemo-
globin level was related to hypermenorrheaplatelet count and also neutrophil and lymphocyte 
count showed cyclic decreases over a period of five 
weeks (Figure 1). Anemia as a consequence of 
thrombocytopenia and menorrhagia contributed to 
the clinic picture. The diagnosis of CTP was made. 
Medroxyprogesterone acetate was initiated to con-
trol hypermenorrhea after gynecological consulta-
tion. Tranexamic acid was also added to control 
bleeding symptoms when the patient had nadir 
platelet count. After we accumulated data revealing 
that the patient had thrombocytopenia every five 
weeks, we started to use oral contraceptives and 
tranexamic acid to manage the patient’s menstrua-
tion. With this therapy, hypermenorrhea was con-
trolled, and the patient did not experience any 
major bleeding during the two-year follow-up. 
Discussion
In this case report, a 33-year-old woman with 
CTP misdiagnosed as ITP was presented. She had 
severe thrombocytopenia with bleeding symptoms 
followed by thrombocytosis. She received cortico-
steroids and IVIG therapy with no response. Because 
she had rebound thrombocytosis, we suspected the 
diagnosis of CTP . The observation of this patient 
with weekly platelet counts showed cyclic fluctua-
tion, proving the CTP diagnosis.  
The pathophysiology of CTP is unclear. Some 
potential mechanisms are autoimmune platelet 
destruction, megakaryocytic hypoplasia/aplasia, and 
infectious and hormonal etiology. There are some 
reported cases that respond well to hormonotherapy, 
especially to danazol. It has been shown that most 
female CTP patients had low platelet counts during 
menstruation. It has also been shown that hysterec-
tomy and bilateral salpingo-oophorectomy did not 
affect platelet fluctuation in those patients [2].
In our case, platelet cycles occurred in synchro-
ny with menstruation (Figure 1). Because our 
patient had hypermenorrhea causing anemia, we 
used oral contraceptives for controlling menstrua-
tion. Although the oral contraceptive drug did not 
affect platelet fluctuations, it helped to manage the 
time of menstruation. We also used tranexamic 
acid to decrease bleeding symptoms. 
The association between CTP and infections has 
not been described. To date, CTP had been report-
ed only in dogs via Ehrlichia platys [9,10] and it was 
documented to resolve after antibiotherapy [11]. 
However, there is not yet any data about human 
ehrlichiosis causing CTP . 
Considering that HBsAg in our patient was posi-
tive, the association between CTP and hepatitis B 
needs to be studied. There are some case reports 
about isolated thrombocytopenia in the course of 
acute or chronic hepatitis B [12,13]; however, a 
CTP-hepatitis B association is unknown. 
In conclusion, CTP is a rare disorder, but in 
patients with ITP who have not responded to sev-
eral treatments and have rebound thrombocytosis, 
a diagnosis of CTP should be considered.
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